Humera Khurshid

1.1k total citations
24 papers, 342 citations indexed

About

Humera Khurshid is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Humera Khurshid has authored 24 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Humera Khurshid's work include Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (5 papers) and Neuroendocrine Tumor Research Advances (3 papers). Humera Khurshid is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (5 papers) and Neuroendocrine Tumor Research Advances (3 papers). Humera Khurshid collaborates with scholars based in United States and Canada. Humera Khurshid's co-authors include Robert C. Black, Howard Safran, Rawad Elias, William M. Sikov, Jaroslaw T. Hepel, Ariel E. Birnbaum, Kathy Radie-Keane, Andrew Schumacher, Brigid M. O'Connor and Thomas A. DiPetrillo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Humera Khurshid

23 papers receiving 337 citations

Peers

Humera Khurshid

ONCOL

PRM

SURGE

Dayssy A. Diaz United States

R. Axelrod United States

Kie Kian Ang United States

Everett E. Vokes United States

Maike Trommer Germany

Rakesh Surapaneni United States

Janine M. Davies Canada

Peey‐Sei Kok Australia

Richard Mansour United States

Croix C. Fossum United States

Dayssy A. Diaz United States

Humera Khurshid

151 ×0.8

ONCOL

114 ×0.8

PRM

118 ×1.5

SURGE

50 ×0.7

52 ×1.3

Citations per year, relative to Humera Khurshid Humera Khurshid (= 1×) peers Dayssy A. Diaz

Countries citing papers authored by Humera Khurshid

Since Specialization

Citations

This map shows the geographic impact of Humera Khurshid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Humera Khurshid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Humera Khurshid more than expected).

Fields of papers citing papers by Humera Khurshid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Humera Khurshid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Humera Khurshid. The network helps show where Humera Khurshid may publish in the future.

Co-authorship network of co-authors of Humera Khurshid

This figure shows the co-authorship network connecting the top 25 collaborators of Humera Khurshid. A scholar is included among the top collaborators of Humera Khurshid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Humera Khurshid. Humera Khurshid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kalemkerian, Gregory P., Humera Khurshid, Nofisat Ismaila, et al.. (2024). Systemic Therapy for Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update. Journal of Clinical Oncology. 43(1). 101–105. 5 indexed citations

Khurshid, Humera, Nofisat Ismaila, Millie Das, et al.. (2024). Systemic Therapy for Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update Clinical Insights. JCO Oncology Practice. 21(6). 754–758.

El‐Deiry, Wafik S., Stephanie L. Graff, Christopher G. Azzoli, et al.. (2023). BrUOG 387: Phase Ib investigator-initiated trial of a heat shock protein 90 inhibitor (HSP90i) combined with a CDK4/6i in advanced breast cancer progressing on CDK4/6i and in solid tumors with retinoblastoma (Rb)-deficiency (IND163592).. Journal of Clinical Oncology. 41(16_suppl). TPS3167–TPS3167. 1 indexed citations

Rudolph, James L., et al.. (2023). Assessment of Frailty and Risk of Chemotherapy Toxicity at a Geriatric-Oncology Multidisciplinary Clinic.. PubMed. 106(4). 13–18. 2 indexed citations

Khurshid, Humera, Nofisat Ismaila, Raetasha Dabney, et al.. (2023). Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline. Journal of Clinical Oncology. 41(35). 5448–5472. 22 indexed citations

DiPetrillo, Thomas A., et al.. (2022). Predictors of Pneumonitis in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation Followed by Consolidative Durvalumab. Advances in Radiation Oncology. 8(2). 101130–101130. 13 indexed citations

Pelcovits, Ari, et al.. (2021). Risk factors for immune mediated adverse events with immune checkpoint inhibitors.. Journal of Clinical Oncology. 39(15_suppl). 2622–2622. 2 indexed citations

Ouseph, Madhu M., Humera Khurshid, Russell W. Madison, et al.. (2019). <p>TKI-resistant <em>ALK</em>-rearranged lung adenocarcinoma with secondary CTNNB1 p.S45V and tertiary ALK p.I1171N mutations</p>. PubMed. Volume 10. 81–86. 2 indexed citations

Riley, David R., Adam J. Olszewski, Ariel E. Birnbaum, et al.. (2018). Radium-223 following front-line chemotherapy for patients with non-small cell lung cancer and bone metastases.. Journal of Clinical Oncology. 36(15_suppl). e21211–e21211. 2 indexed citations

10.

Schumacher, Andrew, et al.. (2017). Informed consent in oncology clinical trials: A Brown University Oncology Research Group prospective cross-sectional pilot study. PLoS ONE. 12(2). e0172957–e0172957. 22 indexed citations

11.

Elias, Rawad, et al.. (2016). Immune Checkpoint Inhibitors in Older Adults. Current Oncology Reports. 18(8). 47–47. 47 indexed citations

12.

Hepel, Jaroslaw T., K.L. Leonard, Howard Safran, et al.. (2016). Stereotactic Body Radiation Therapy Boost After Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer: A Phase 1 Dose Escalation Study. International Journal of Radiation Oncology*Biology*Physics. 96(5). 1021–1027. 30 indexed citations

13.

Olszewski, Adam J., Andrew Schumacher, Kimberly Perez, et al.. (2016). Clinical Trial Accrual Targeting Genomic Alterations After Next-Generation Sequencing at a Non-National Cancer Institute–Designated Cancer Program. Journal of Oncology Practice. 12(4). e396–e404. 12 indexed citations

14.

Khurshid, Humera, et al.. (2013). Targeting Genomic Alterations in Squamous Cell Lung Cancer. Frontiers in Oncology. 3. 195–195. 14 indexed citations

15.

Khurshid, Humera, et al.. (2013). Phase I study of ridaforolimus with cetuximab for patients with advanced non-small cell lung cancer (NSCLC), colorectal cancer, and head and neck cancer.. Journal of Clinical Oncology. 31(15_suppl). 8075–8075. 3 indexed citations

16.

Khurshid, Humera, Thomas A. DiPetrillo, Thomas Ng, et al.. (2012). A Phase I Study of Dasatinib with Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer. SHILAP Revista de lepidopterología. 2. 56–56. 10 indexed citations

17.

Birnbaum, Ariel E., Ritesh Rathore, Priscilla Merriam, et al.. (2012). Cetuximab, Paclitaxel, Carboplatin, and Radiation for Head and Neck Cancer. American Journal of Clinical Oncology. 37(2). 162–166. 5 indexed citations

18.

Pricolo, Victor E., Jorge A. Lagares-García, Adam Klipfel, et al.. (2010). Neoadjuvant Bevacizumab, Oxaliplatin, 5-Fluorouracil, and Radiation for Rectal Cancer. International Journal of Radiation Oncology*Biology*Physics. 82(1). 124–129. 76 indexed citations

19.

Khurshid, Humera, et al.. (2010). The evolving role of histology in the treatment of non-small cell lung cancer.. PubMed. 93(10). 317–9. 2 indexed citations

20.

Balogun, Rasheed A., Joseph Palmisano, André A. Kaplan, et al.. (2001). Shunt nephritis from Propionibacterium acnes in a solitary kidney. American Journal of Kidney Diseases. 38(4). e18.1–e18.7. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact